NCT00283023

Oligodendrocyte Progenitor Cell Culture From Human Brain

Phase 1: Oligodendrocyte Progenitor Cell Culture From Human Brain

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 5 (actual)
• Sponsor: Department of Medical Services Ministry of Public Health of Thailand · Other Government
• Sex: All
• Age: 20 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

Recent developments in the understanding of stem- and progenitor cell differentiation raises hopes that brain damage in chronic neurological diseases may become repaired by systemic or focal transplantation of such cells. Clinical trials of stem- or progenitor cell transplantation in multiple sclerosis are currently premature. The researchers developed a protocol for human oligodendrocyte progenitor cell culture from human brain for the treatment of demyelinating disease.

Detailed description

Oligodendrocyte progenitor cell line were cultures and will be transplanted into the patient with Multiple sclerosis.

Conditions

• Demyelinating Diseases

Interventions

Type	Name	Description
PROCEDURE	Oligodendrocyte progenitor cell culture/craniotomy	Oligodendrocyte progenitor cell culture protocol of Rajavithi Hospital will be apply

Timeline

• Start date: 2007-12-01
• Primary completion: 2010-12-01
• Completion: 2010-12-01
• First posted: 2006-01-27
• Last updated: 2020-10-19

Locations

1 site across 1 country: Thailand